Navigation Links
Can an over-the-counter vitamin-like substance slow the progression of Parkinson's disease?
Date:9/21/2009

Rush University Medical Center is participating in a large-scale, multi-center clinical trial in the U.S. and Canada to determine whether a vitamin-like substance, in high doses, can slow the progression of Parkinson's disease, a neurodegenerative disorder that affects about one million people in the United States.

"At present, the very best therapies we have for Parkinson's can only mask the symptoms they do not alter the underlying disease," said neurologist Dr. Katie Kompoliti, a specialist in movement disorders. "Finding a treatment that can slow the degenerative course of Parkinsons's is the holy grail of Parkinson's research."

The substance being tested, called coenzyme Q10, is produced naturally in the body and is an important link in the chain of chemical reactions that produce energy in mitochondria, the "powerhouses" of cells. The enzyme is also a potent antioxidant a chemical that "mops up" potentially harmful chemicals generated during normal metabolism.

Several studies have shown that Parkinson's patients have impaired mitochondrial function and low levels of coenzyme Q10. Moreover, laboratory research has demonstrated that coenzyme Q10 can protect the area of the brain damaged in Parkinson's.

The Phase III clinical trial, a large, randomized study with a control group, follows an earlier investigation that tested several doses of coenzyme Q10 in a small group of patients with early-stage Parkinson's disease. The highest dose, 1,200 mg, appeared promising. Over the course of 16 months, patients taking this dose experienced significantly less decline than other patients in motor (movement) function and ability to carry out activities of daily living, such as feeding or dressing themselves.

But researchers involved in the study, including Kompoliti, were cautious about their findings, citing the need for a more extensive review to confirm the results.

In the present trial, funded by the National Institutes of Health and the National Institute of Neurological and Disorders and Stroke, 600 patients will be enrolled at 60 centers in the U.S. and Canada. Two dosages of coenzyme Q10 are being tested,1,200 mg and 2,400 mg, delivered in maple nut-flavored chewable wafers that also contain vitamin E.

Participants in the study will be evaluated periodically over 16 months for symptoms of Parkinson's disease, including tremor, stiffness of the limbs and trunk, impaired balance and coordination, and slowing of movements. They will also be assessed for ability to perform daily activities, overall quality of life, and need to take medications to alleviate symptoms.


'/>"/>

Contact: Sharon Butler
Sharon_Butler@rush.edu
312-942-7816
Rush University Medical Center
Source:Eurekalert

Related biology news :

1. Airway cells use tasting mechanism to detect and clear harmful substances
2. Natural brain substance blocks weight gain in mice, UT Southwestern researchers discover
3. UI researchers find potentially toxic substance present in Chicago air
4. Substance found in fruits and vegetables reduces likelihood of the flu
5. Argyrin: Natural substance raises hope for new cancer therapies
6. Tests show LLNL detection instrument can monitor the air for all major terrorist threat substances
7. Substance in red wine found to keep hearts young
8. Researchers develop new ultrasensitive assay to detect most poisonous substance known
9. Motor neuron disease and toxic substances: Possible link?
10. New method reveals substances on surfaces of any kind
11. Green tea may affect prostate cancer progression
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/13/2017)... 13, 2017 UBM,s Advanced Design and Manufacturing ... feature emerging and evolving technology through its 3D Printing ... run alongside the expo portion of the event and ... demonstrations focused on trending topics within 3D printing and ... manufacturing event will take place June 13-15, 2017 at the ...
(Date:4/11/2017)... , April 11, 2017 No two ... researchers at the New York University Tandon School ... Engineering have found that partial similarities between prints ... used in mobile phones and other electronic devices ... The vulnerability lies in the fact that ...
(Date:4/5/2017)... , April 5, 2017 Today HYPR ... that the server component of the HYPR platform is ... providing the end-to-end security architecture that empowers biometric authentication ... HYPR has already secured over 15 million users across ... manufacturers of connected home product suites and physical access ...
Breaking Biology News(10 mins):
(Date:8/14/2017)... ... ... The Conference Forum has confirmed the one-day agenda for the ... 2017 at the Marriott Copley Place in Boston, MA. , Returning as program chair ... Pfizer Innovative Research Lab, Pfizer, who leads 19 industry speakers in discussing how and ...
(Date:8/11/2017)... ... 11, 2017 , ... A staple in the community for more than 60 ... key elements including a new digital marketing strategy and updated logo. , As part ... has partnered with the South Texas Blood & Tissue Center for the month of ...
(Date:8/11/2017)... ... 2017 , ... “There is an increasing consumer call for ... ingredients,” said Matt Hundt, President of Third Wave Bioactives. “Combining the strong discovery ... of Biorigin will allow us to bring truly novel fermented ingredient technologies to ...
(Date:8/10/2017)... ... August 09, 2017 , ... Teachers ... as students. From August 14th through the 16th, the University City Science Center ... the summer of 2016, provides Philadelphia-based middle school educators an opportunity for professional ...
Breaking Biology Technology: